Search

Search Results

12 results for “V. D'Agostino”

Sort by

P060 | CLINICAL CHARACTERIZATION OF A NOVEL DE NOVO MUTATION IN THE CACNA1A GENE (C.3277DEL) ASSOCIATED WITH MIGRAINE WITHOUT AURA AND EPISODIC ATAXIA

W. Dell'Oste^1|2, M. Romozzi^1|2, S. Spartano³, C. Vollono^1|2, F. Danilo Tiziano³, P. Calabresi^1|2 | ¹University Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy; ²Neurology, Department of Neuroscience, Sensory Organs and Thorax, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; ³Section of Genomic Medicine, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

03-11-2026

DOI https://doi.org/10.4081/cc.2026.16016
- 0 abstract views
- 0 PDF
OC09 | TOBACCO/NICOTINE-RELATED HEADACHE AS A CANDIDATE PHENOTYPE FOR ICHD-4: INSIGHTS FROM THE JASTIS STUDY, A JAPANESE CROSS-SECTIONAL ANALYSIS

M. Katsuki^1|2, M. Romozzi^3|4, Y. Matsumori⁵, K. Moran², T. Ward², T. Tabuchi⁷ | ¹Nagaoka University of Technology, Japan; ²Insight Research Ireland Centre for Data Analytics, Ireland; ³Università Cattolica del Sacro Cuore, Italy; ⁴Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy; ⁵Sendai Headache and Neurology Clinic, Japan; ⁶Tohoku University, Japan

03-11-2026

DOI https://doi.org/10.4081/cc.2026.15947
- 0 abstract views
- 0 PDF
P092 | A PRACTICAL DOMAIN-SPECIFIC RETRIEVAL-AUGMENTED GENERATION FRAMEWORK FOR HEADACHE RESEARCH

L. Francesco Iannone¹, M. Lovino², M. Romozzi^3|4, C. Vollono⁴, P. Calabresi^3|4, C. Benatti², L. Pani^2|5, F. Tascedda¹ | ¹Department of Life Sciences, University of Modena and Reggio Emilia, Italy; ²Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; ³Dipartimento Universitario di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy; ⁴Neurologia, Dipartimento di neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; ⁵Department of Psychiatry and Behavioral Sciences, University of Miami, USA

03-11-2026

DOI https://doi.org/10.4081/cc.2026.16048
- 0 abstract views
- 0 PDF
P089 | PRELIMINARY VALIDATION OF THE ITALIAN VERSION OF THE UTAH PHOTOPHOBIA SYMPTOM IMPACT SCALE (UPSIS-2) IN PATIENTS WITH MIGRAINE

A.M. Chiarandon¹, E.M. Piella¹, V. Batti¹, G. Sebastianelli², F. Ferrandes¹, M. Corrado³, M. Romozzi⁴, F. De Santis⁵, C. Fasano⁶, F. Lazzerini⁷, L. F. Iannone⁸, A. Munafò⁹, R. Ornello¹⁰, E. Rubino^1|11, I. Rainero^1|11 | ¹Department of Neuroscience “Rita Levi Montalcini”, University of Turin, Italy; ²Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Polo Pontino, Latina, Italy; ³Department of Brain and Behavioral Sciences, University of Pavia, Italy; ⁴Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome; Università Cattolica del Sacro Cuore, Rome, Italy; ⁵Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy; ⁶Headache and Cerebrovascular Diseases Center, Neurology Unit 2, Careggi University Hospital, Florence, Italy; ⁷Department of Humanities, University of Turin, Italy; ⁸Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; ⁹Headache center and Clinical pharmacology unit, AOU Careggi, Florence, Italy; ¹⁰Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy; ¹¹Headache Center, Department of Neuroscience and Mental Health, City of Health and Science of Turin, Italy, on behalf of SISC Junior Group

03-11-2026

DOI https://doi.org/10.4081/cc.2026.16045
- 2 abstract views
- 0 PDF
P028 | WORSENING OF MIGRAINE AFTER DISCONTINUATION OF ANTI-CGRP MONOCLONAL ANTIBODIES: PATIENTS WITHOUT RECURRENCE FOR AT LEAST 6 MONTHS

M. Katsuki^1|2, M. Romozzi^3|4, S. Ooba⁵, Y. Matsumori⁶, K. Moran², T. Ward², S. Ishii⁷ | ¹Nagaoka University of Technology, Japan; ²Insight Research Ireland Centre for Data Analytics, Ireland; ³Università Cattolica del Sacro Cuore, Italy; ⁴Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy; ⁵Ooba Clinic for Neurosurgery & Headache, Japan; ⁶Sendai Headache and Neurology Clinic, Japan; ⁷Daidai Clinic Kudanshita Headache Clinic, Japan

03-11-2026

DOI https://doi.org/10.4081/cc.2026.15984
- 0 abstract views
- 0 PDF
P046 | FROM TRIGGERS TO PATTERNS: THE ROLE OF NUTRITION IN MIGRAINE SUSCEPTIBILITY — A NARRATIVE REVIEW

D. Pala^1|2, F. Tosto³, A. Munafò^4|5, A. Burgalassi^4|5, M. Romozzi^6|7, L. Francesco Iannone^8|9, C. Vollono^6|7, P. Calabresi^6|7, F. Casillo¹⁰, C. Di Lorenzo¹⁰ | ¹Department of Medical Science and Public Health, University of Cagliari, Italy; ²Department of Biomedical Sciences, University of Cagliari, Italy; ³Department of Neuroscience, Giovanni Paolo II Hospital, Catanzaro, Italy; ⁴Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Italy; ⁵Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy; ⁶Department of Neurosciences, Università Cattolica del Sacro Cuore, Rome, Italy; ⁷Neurology, Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; ⁸Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; ⁹Digital and Predictive Medicine, Pharmacology, Clinical Metabolic Toxicology - Headache Center and Drug Abuse, Laboratory of Clinical Pharmacology and Pharmacogenomics, Policlinico di Modena, Italy; ¹⁰Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Polo Pontino, ICOT Istituto Marco Pasquali, Latina, Italy

03-11-2026

DOI https://doi.org/10.4081/cc.2026.16002
- 0 abstract views
- 0 PDF
P097 | SEQUENTIAL MACHINE LEARNING MODELS FOR PREDICTING ONABOTULINUMTOXINA RESPONSE IN CHRONIC MIGRAINE: A COHORT STUDY

G. Vigani¹, M. Romozzi^2|3, A. Burgalassi¹, A. Lokhawandala⁴, C. Vollono^2|3, P. Calabresi^2|3, F. Tascedda⁵, A. Chiarugi^1|6, F. De Cesaris¹, L. Francesco Iannone⁷ | ¹Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy; ²Dipartimento Universitario di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy; ³Neurologia, Dipartimento di neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; ⁴Drexel University, Philadelphia, USA; ⁵Department of Life Sciences, University of Modena and Reggio Emilia, Italy; ⁶Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Italy; ⁷Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy

03-11-2026

DOI https://doi.org/10.4081/cc.2026.16053
- 1 abstract views
- 0 PDF
P093 | GAINER-AI: PREDICTING ACUTE RIMEGEPANT RESPONSE IN MIGRAINE USING MACHINE LEARNING IN A MULTICENTER REAL-WORLD COHORT

M. Romozzi^1|2, A. Lokhawandala³, G. Vaghi^4|5, G. Sebastianelli⁶, R. Ornello⁷, F. Casillo⁶, A. Russo⁸, M. Silvestro⁸, F. Pistoia⁹, G. Saporito⁹, G. Dalla Volta¹⁰, M. Bolchini¹⁰, A. Burgalassi¹¹, G. Vigani¹¹, D. Antonio Montisano¹², L. Grazzi¹², M. Pia Prudenzano¹³, D. Mascarella¹⁴, E. Mampreso¹⁵, G. Avino¹⁶, M. Valente¹⁷, G. Carlucci¹⁸, S. Guerzoni¹⁹, S. Battistini²⁰, A. Granato²¹, E. Maria Piella²², I. Rainero²², M. Albanese²³, M. Trimboli²⁴, A. Doretti²⁵, F. De Santis⁷, S. Sacco⁷, C. Tassorelli^4|5, S. Di Tella²⁶, C. Vollono^1|2, P. Calabresi^1|2, R. De Icco^4|5, L. Francesco Iannone²⁷ | ¹Dipartimento Universitario di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy; ²Neurologia, Dipartimento di neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; ³Drexel University, Philadelphia, USA; ⁴Department of Brain and Behavioral Sciences, University of Pavia, Italy; ⁵Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy; ⁶Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome Polo Pontino, Latina, Italy; ⁷Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy; ⁸Headache Centre, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy; ⁹Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy; ¹⁰Headache Center of Clinical Neurology of Istituto Clinico Città Di Brescia, Italy; ¹¹Department of Health Sciences, University of Florence, Italy; ¹²Neuroalgology Unit and Headache Center, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; ¹³Headache Center, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy; ¹⁴IRCCS Istituto Di Scienze Neurologiche Di Bologna, Programma Cefalee e Algie Facciali, Italy; ¹⁵Headache Centre, Neurology - Euganea, Health Unit, Padua, Italy; ¹⁶Neurology Unit, Ospedale Santo Stefano, USL Toscana Centro, Prato, Italy; ¹⁷Clinical Neurology, Azienda Sanitaria Universitaria Friuli Centrale, Presidio Ospedaliero Santa Maria Della Misericordia, Udine, Italy; ¹⁸NEUROFARBA Department, University of Florence - AOU Careggi, Italy; ¹⁹Digital and Predictive Medicine, Pharmacology, Clinical Metabolic Toxicology-Headache Center and Drug Abuse, Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico, Modena, Italy; ²⁰Department of Medical, Surgical and Neurological Sciences, University of Siena, Italy; ²¹Headache Centre, Clinical Unit of Neurology, School of Neurology, Department of Medicine, Surgery and Health Sciences, University Hospital and Health Services of Trieste, ASUGI, University of Trieste, Italy; ²²Department of Neurosciences “Rita Levi Montalcini”, University of Turin, Italy; ²³Unit of Neurology, Department of Systems Medicine, Tor Vergata University, Rome, Italy; Unit of Neurology - IRCCS Neuromed, Pozzilli (IS), Italy; ²⁴Headache Centre, Neurology Unit, AOU Renato Dulbecco, Catanzaro, Italy; ²⁵Department of Neurology- Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy; ²⁶Dipartimento di Psicologia, Università Cattolica del Sacro Cuore, Milan, Italy; ²⁷Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy

03-11-2026

DOI https://doi.org/10.4081/cc.2026.16049
- 1 abstract views
- 0 PDF
P064 | MIGRAINE HISTORY IN PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE DEVELOPING CEREBRAL VASOSPASM AND DELAYED CEREBRAL ISCHEMIA: A CASE SERIES

G. Rosaria Melis¹, F. Marrama², A. Mascolo², V. D'Agostino¹, M. Diomedi², D. Centonze¹, M. Albanese¹ | ¹Headache Center, Department of Systems Medicine, Policlinico Tor Vergata, University of Rome Tor Vergata, Italy; ²Stroke Unit, Department of Systems Medicine, Policlinico Tor Vergata, University of Rome Tor Vergata, Italy

03-11-2026

DOI https://doi.org/10.4081/cc.2026.16020
- 0 abstract views
- 0 PDF
P045 | CLINICAL AND NEUROPHYSIOLOGICAL EFFECTS OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION IN PATIENTS WITH REFRACTORY CHRONIC CLUSTER HEADACHE

G. Martino^1|2, M. Conti^1|2, V. D'Agostino^1|2, F. Carparelli^1|2, A. Meo^1|2, L. Orsini^1|2, D. Centonze^1|2, M. Albanese^1|2 | ¹Department of Systems Medicine, University of Rome Tor Vergata, Italy; ²Neurology Unit, Tor Vergata University Hospital, Rome, Italy

03-11-2026

DOI https://doi.org/10.4081/cc.2026.16001
- 0 abstract views
- 0 PDF
P055 | DELTA-BAND HYPERCONNECTIVITY AS A POTENTIAL MARKER OF MIGRAINE SEVERITY AND CHRONIFICATION: A RESTING-STATE HIGH-DENSITY EEG STUDY

G. Martino^1|2, M. Conti^1|2, V. D'Agostino^1|2, F. Carparelli^1|2, A. Meo^1|2, D. Centonze^1|2, M. Albanese^1|2 | ¹Department of Systems Medicine, University of Rome Tor Vergata, Italy; ²Neurology Unit, Tor Vergata University Hospital, Rome, Italy

03-11-2026

DOI https://doi.org/10.4081/cc.2026.16011
- 0 abstract views
- 0 PDF
OC07 | LONG-TERM COMBINATION WITH ONABOTULINUMTOXINA AND ATOGEPANT TO ACHIEVE HIGHER STANDARDS OF MIGRAINE CONTROL: A 52-WEEK, PROSPECTIVE, REAL-WORLD EVALUATION (SYNERGY STUDY)

L. Francesco Iannone¹, M. Romozzi^2|3, A. Russo⁴, I. Finkelstein⁵, D. Seabi⁶, A. Ahlden⁶, A. Hege Aamodt^7|8|9, P. Calabresi^2|3, C. Vollono³, E. Caronna^10|11, P. Pozo-Rosich^10|11, E. Andreas Tronvik^8|12|13, C. Sundal^6|12 | ¹Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; ²Dipartimento Universitario di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy; ³Neurologia, Dipartimento di neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; ⁴Inter-departmental Program of Headache Medicine and Primary Pain Syndromes, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy; ⁵Toronto Headache and Pain clinic; Pain Clinic, Toronto, Canada; ⁶NeuroClinicNorway, Lillestrøm, Norway; ⁷Department of Neurology, Oslo University Hospital, Rikshospitalet, Norway; ⁸NorHead, Norwegian Headache Research Centre; NTNU, Norwegian University of Science and Technology, Trondheim, Norway; ⁹Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, UK; ¹⁰Headache and Neurological Pain Research Group, Vall d’Hebron Research Institute, Department of Neuroscience, Universitat Autònoma de Barcelona, Spain; ¹¹Headache Clinic, Neurology Department, Vall d’Hebron Hospital, Barcelona, Spain; ¹²Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway; ¹³Neuroclinic, St. Olavs Hospital, Trondheim, Norway

03-11-2026

DOI https://doi.org/10.4081/cc.2026.15945
- 0 abstract views
- 0 PDF

1 - 12 of 12 items